Vermillion Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Vermillion Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$81K	Sell	426 -105	-20%	-$18K	0.02%	466
2026 Q1	$89.7K	Hold	531	–	–	0.04%	154
2025 Q4	$89.6K	Buy	531 +106	+25%	+$17.2K	0.04%	146
2025 Q3	$61.4K	Hold	425	–	–	0.02%	515
2025 Q2	$53.8K	Sell	425 -105	-20%	-$12.9K	0.03%	173
2025 Q1	$67.8K	Hold	530	–	–	0.02%	463
2024 Q4	$70K	Buy	+530	New	+$74.5K	0.04%	154

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Vermillion Wealth Management's IBB Position: Q2 2026 in Review

Vermillion Wealth Management reduced its iShares Biotechnology ETF (IBB) stake by 20% in Q2 2026, selling an estimated $18K and leaving 426 shares worth $81K. The position accounts for 0.02% of the portfolio, ranked #466.

Vermillion Wealth Management first reported a position in IBB in Q4 2024 and has held it in 7 quarters since. The position peaked at $89.7K in Q1 2026. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Vermillion Wealth Management held 426 shares of iShares Biotechnology ETF worth $81K as of Q2 2026.
Vermillion Wealth Management sold 105 iShares Biotechnology ETF shares in Q2 2026, an estimated $18K.
iShares Biotechnology ETF made up 0.02% of Vermillion Wealth Management's portfolio in Q2 2026, its #466 holding.
Vermillion Wealth Management first reported a position in iShares Biotechnology ETF in Q4 2024 and has held it in 7 quarters since.
Vermillion Wealth Management's iShares Biotechnology ETF position peaked at $89.7K in Q1 2026.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Vermillion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.